Brunei Darussalam vs Zimbabwe: Prevalence rate of hypertension in women aged 30-79
Brunei Darussalam
45.6
in 2019
Zimbabwe
46.4
in 2019
Brunei Darussalam rank
17th
Zimbabwe rank
15th
Prevalence rate of hypertension in women aged 30-79 over time
- Brunei Darussalam
- Zimbabwe
How they compare
Zimbabwe currently reports 46.4 against 45.6 in Brunei Darussalam, a difference of 0.8.
Across all 30 years both countries report, Zimbabwe has been ahead every year.
Brunei Darussalam ranks 17th and Zimbabwe ranks 15th of 195 countries.
Zimbabwe has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Brunei Darussalam | Zimbabwe | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 36.93 | 43.2 | 6.27 | Zimbabwe |
| 2000s | 40.45 | 46.18 | 5.73 | Zimbabwe |
| 2010s | 44.27 | 47.13 | 2.86 | Zimbabwe |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in women aged 30-79, Brunei Darussalam or Zimbabwe?
- Zimbabwe, at 46.4 against 45.6 in Brunei Darussalam as of 2019.
- What is the difference in prevalence rate of hypertension in women aged 30-79 between Brunei Darussalam and Zimbabwe?
- 0.8, with Zimbabwe ahead.
- How many years of comparable data are there for Brunei Darussalam and Zimbabwe?
- 30 years are reported by both, from 1990 to 2019.
- How do Brunei Darussalam and Zimbabwe rank globally for prevalence rate of hypertension in women aged 30-79?
- Brunei Darussalam ranks 17th and Zimbabwe ranks 15th of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in women aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of female population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.